PNN-61397-79687
2 vaccinations
2 coded responses
8 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 730 / OK
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-04
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: GoodFree text: Mild light-headedness 8hrs post injection. Fine otherwiseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: All symptoms were about 12 hours post-injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-09-02
-
2021-10-29
Dose 2 — Moderna
- 2021-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Moderna | No |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Mild light-headedness 8hrs post injection. Fine otherwise
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): All symptoms were about 12 hours post-injection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release